Evidence for platelet αIIbβ3 activation despite elevated cytosolic cAMP

Thrombosis and Haemostasis

Volumn 85, Issue 2, 2001, Pages 320-325

  Riondino, S ^a   Gazzaniga, P P ^a   Pulcinelli, F M ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

cAMP; G protein; PKC; Platelet aggregation; PLC

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ADENOSINE DIPHOSPHATE; ADRENALIN; BUCLADESINE; CALCIUM; CYCLIC AMP; FIBRINOGEN; G PROTEIN COUPLED RECEPTOR; INTEGRIN; IONOMYCIN; PROTEIN KINASE C; PROTEIN KINASE C ACTIVATOR; SNAKE VENOM; THROMBOXANE A2; 1-OLEOYL-2-ACETYLGLYCEROL; ANTITHROMBOCYTIC AGENT; CONVULXIN; DIACYLGLYCEROL; FIBRINOGEN RECEPTOR; GLYCEROL 2 ACETATE 1 OLEATE; ILOPROST; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; LECTIN;

ARTICLE; CALCIUM TRANSPORT; CYCLIC AMP BLOOD LEVEL; CYTOSOL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; CHEMISTRY; CYTOLOGY; DRUG EFFECT; METABOLISM;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; BLOOD PLATELETS; CROTALID VENOMS; CYCLIC AMP; CYTOSOL; DIGLYCERIDES; EPINEPHRINE; FIBRINOGEN; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; HUMANS; ILOPROST; LECTINS, C-TYPE; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX;

EID: 0034746159     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1615687     Document Type: Article

References (21)

1. Regulation of human platelet activation - Analysis of cyclooxygenase and cyclic AMP-dependent pathways
2. Inhibition by forskolin of cytosolic calcium rise, shape change and aggregation in quin2-loaded human platelets
3. Inhibition of platelet-activating-factor-induced human platelet activation by prostaglandin D2. Differential sensitivity of platelet transduction processes and functional responses to inhibition by cyclic AMP
4. The rapid formation of inositol phosphates in human platelets by thrombin is inhibited by prostacyclin
5. Cyclic nucleotide-elevating vasodilators inhibit platelet aggregation at an early step of the activation cascade
6. Functional relationship between cyclic AMP-dependent protein phosphorylation and platelet inhibition
7. Prostacyclin inhibits mobilisation of fibrinogen-binding sites on human ADP- and thrombin-treated platelets
8. Protein kinase C and cyclic AMP regulate reversible exposure of binding sites for fibrinogen on the glycoprotein IIb/IIIa complex of human platelets
9. Role of cyclic nucleotide-dependent protein kinases and their common substrate VASP in the regulation of human platelets
10. Phosphorylation of focal adhesion vasodilators-stimulated phosphoprotein at Ser157 in intact human platelets correlates with fibrinogen receptor inhibition
11. Regulation of platelet anchorage and signalling by integrin αIIbβ3
12. The vasodilator-stimulated phosphoprotein (VASP) is involved in cGMP- and cAMP-mediated inhibition of agonist-induced platelet aggregation, but is dispensable for smooth muscle function
13. Protein kinase C activation is not a key step in ADP-mediated exposure of fibrinogen receptors on human platelets
14. Concomitant activation of Gi and Gq protein-coupled receptors does not require an increase in cytosolic calcium for platelet aggregation
15. Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation
16. Alfa-2A adrenergic receptors activate protein kinase C in human platelets via a pertussis toxin-sensitive G-protein
17. i protein-coupled receptor and protein kinase C or phospholipase C is required for platelet aggregation
18. 2+ dependent protein kinases
19. Platelet activation and signal transduction by convulxin, a C-type lectin from Crotalus durissus terrificus (tropical rattlesnake) venom via the p62/GPVI collagen receptor
20. Platelet 5-HT uptake and release stopped rapidly by formaldehyde
21. Platelet responses promoted by the activation of protein kinase C or the increase of cytosolic Ca2+ are potentiated by adrenaline. Effects of cAMP and staurosporine